Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • USO vs MRNA✓SelectedUSD · MRNAUSO vs MRNA performance historyLatest closeAs of+1.12%11/20
Stock and ETF performance explorer

USO vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+93.1%
MRNA return
+153.9%
Excess return
-60.8%
Maximum drawdown
-32.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D+1.1%-2.2%+3.3%+1.1%
7D-4.1%-12.7%+8.6%-4.4%
30D-12.6%-20.7%+8.0%-12.9%
3M+3.8%+46.3%-42.5%+4.6%
6M-3.2%+305.2%-308.5%+0.8%
YTD+101.9%+561.2%-459.3%+109.1%
1Y+99.0%+772.1%-673.0%+106.2%
3Y+93.1%+147.0%-53.8%+79.8%
All+93.1%+153.9%-60.8%+79.8%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling